U.S. federal trademark · Serial No. 97229686 · Reg. No. 330
Licensing of intellectual property in the field of pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments; licensing of intellectual property in the field of pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to treat mental conditions, illnesses, and disorders
Wholesale distributorship featuring pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments; wholesale distributorship featuring pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to treat mental conditions, illnesses and disorders
Downloadable computer applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable computer applications for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; downloadable computer software applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable computer software applications for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; medical systems comprising recorded and downloadable software and/or hardware for monitoring, sensing, stimulating, measuring, and training brain and neural activity; medical alert response systems comprising recorded and downloadable software and/or hardware for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; downloadable software as a Medical Device (SaMD) for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable software as a Medical Device (SaMD) for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; downloadable software as a Medical Device (SaMD) for stimulating nerves
Pharmaceutical preparations for the treatment of central nervous system conditions, illnesses, and disorders; pharmaceutical products for the treatment of central nervous system conditions, illnesses, and disorders; pharmaceutical preparations for the treatment of mental conditions, illnesses, and disorders; pharmaceutical drugs for the treatment of mental conditions, illnesses, and disorders; psychedelic pharmaceuticals for the treatment of central nervous system conditions, illnesses, and disorders; psychedelic-based medicines for the treatment of central nervous system conditions, illnesses, and disorders; neurogenerative pharmaceutical drugs for the treatment of central nervous system [CNS] diseases and mental health disorders; serotonin receptor agonists and antagonist pharmaceutical drugs for the treatment of central nervous system [CNS] diseases and mental health disorders; drug abuse deterrent products in the nature of low-dose pharmaceutical preparations and products, very low-dose pharmaceutical preparations and products, extended release pharmaceutical preparations and products, and tamper resistant pharmaceutical preparations and products; pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms, namely, motivation, attention, accuracy, response speed, perseverance, cognitive engagement, executive function, mood, and/or behavior; pharmaceutical preparations for use in psychedelic therapies for the treatment of mental health disorders;
Pharmaceutical research and development; pharmaceutical drug development; pharmaceutical research and development in the field of mental health treatments; drug discovery services; consultancy pertaining to pharmacology; medical research in the field of mental health conditions, illnesses, and disorders; neuropsychiatric drug discovery services, including pre-clinical and clinical pharmaceutical drug development; pharmaceutical drug development and discovery relating to new chemical entities, neurogenerative drugs, serotonin receptor agonists and antagonist, abuse deterrent drugs, and pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms
Electroencephalogram (EEG) devices, namely, electroencephalography (EEG) device comprising a sensor for monitoring and measuring brain and neural activity for medical diagnostic purposes during use of pharmaceuticals; medical devices for monitoring, sensing, measuring, and training brain and neural activity; medical devices for use in therapy of cognitive states, namely, to monitor, sense, or measure cognitive impairment during use of pharmaceuticals; medical devices for stimulating nerves; medical device used for treating of mental health disorders non-invasively, namely, comprising a sensor for monitoring and measuring brain and neural activity; medical device used in combination with pharmaceutical preparations for treating of mental health disorders non-invasively, namely, for monitoring, sensing, stimulating, measuring, and training brain and neural activity
Custom manufacture for others of pharmaceuticals, pharmaceutical drugs, pharmaceutical preparations and products, and health care products, namely, central nervous system health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; custom manufacture for others of pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products, namely, central nervous system health care products used to treat mental conditions, illnesses and disorders
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.